Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients With Diabetes

International Journal of Nephrology - Egypt
doi 10.1155/2020/4596920
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Hindawi Limited

Related search

Serum Sclerostin Is an Independent Predictor of Mortality in Hemodialysis Patients

BMC Nephrology
Nephrology
2014English

Body Mass Index and Body Composition in Institutionalized Older Adults With Malnutrition, Sarcopenia and Frailty

European Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2019English

Association of Serum Sclerostin With Bone Sclerostin in Chronic Kidney Disease Is Lost in Glucocorticoid Treated Patients

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Current Treatment Methods for Sarcopenia in Patients Undergoing Hemodialysis

Urologicheskie vedomosti
2018English

Insulin Therapy and Body Weight, Body Composition and Muscular Strength in Patients With Type 2 Diabetes Mellitus

Journal of Nutrition and Metabolism
NutritionDieteticsFood ScienceEndocrinologyMetabolismDiabetes
2010English

Serum Paraoxonase and Arylesterase Activities in Hemodialysis Patients

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2000English

Association of Serum Chromium Levels With Malnutrition in Hemodialysis Patients

BMC Nephrology
Nephrology
2019English

Zinc-Α2-Glycoprotein: Is There Association Between This New Adipokine and Body Composition in Hemodialysis Patients?

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2012English

Sarcopenia Strongly Affects Serum Levels of Cystatin C in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy